What We Know So Far About ECG for Pancreatic Pseudocysts

被引:0
|
作者
Kluszczyk, Paulina [1 ]
Jablonska, Beata [2 ]
Serafin, Michal [1 ]
Tobiasz, Aleksandra [1 ]
Kowalczyk, Tomasz [1 ]
Maslanka, Sebastian [1 ]
Chapula, Mateusz [3 ]
Wosiewicz, Piotr [3 ]
Mrowiec, Slawomir [2 ]
机构
[1] Med Univ Silesia, Fac Med Sci Katowice, Dept Digest Tract Surg, Student Sci Soc, Medykow 14 St, PL-40752 Katowice, Poland
[2] Med Univ Silesia, Fac Med Sci Katowice, Dept Digest Tract Surg, Medykow 14 St, PL-40752 Katowice, Poland
[3] Med Univ Silesia, Fac Med Sci Katowice, Dept Gastroenterol & Hepatol, Medykow 14 St, PL-40752 Katowice, Poland
来源
LIFE-BASEL | 2024年 / 14卷 / 11期
关键词
post-inflammatory pancreatic cysts; endoscopic internal drainage; endoscopic cystogastrostomy; GUIDED TRANSMURAL DRAINAGE; EXPANDING METAL STENTS; WALLED-OFF NECROSIS; SURGICAL-TREATMENT; ENDOSCOPIC TREATMENT; FLUID COLLECTIONS; CLINICAL-OUTCOMES; PLASTIC STENTS; MANAGEMENT; EFFICACY;
D O I
10.3390/life14111419
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Endoscopic cysto-gastrostomy (ECG) has become the treatment of choice for pancreatic pseudocysts (PPCs). Endoscopic drainage of PPCs requires the creation of an anastomosis between the lumen of the PPCs and the lumen of the gastrointestinal tract. Various types of stents are used for this purpose. The aim of the study is to compare the indications, quantity, and results of using double pigtail plastic stents (DPPSs) and lumen-apposing fully covered metal stents (LAMSs) in ECG. Methods: A retrospective analysis was conducted of 39 patients (24 men, 15 women) treated for PPCs in the Department of Digestive Tract Surgery and the Department of Gastroenterology and Hepatology between October 2018 and February 2023. The mean age of patients was 51.13 (28-77). Data about etiology, cyst diameter, type, and complications of the stents were collected. Results: DPPSs were placed in smaller cysts (108 vs. 140 millimeters, p = 0.04) and were maintained for a longer duration compared to LAMSs (106 vs. 34 days, p = 0.001). Cyst recurrence was reported less frequently in patients with a LAMS (0 (0%) vs. 4 (19.05%), p = 0.05) and the therapeutic success was non-significantly higher in the LAMS group compared to the DPPS group (100% vs. 85.71%), p = 0.095. Conclusions: Both DPPSs and LAMSs are characterized by high therapeutic success and low complication rates in patients undergoing ECG for PPCs.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Moebius Syndrome: What We Know So Far
    Zaidi, Syed Muhammad Hussain
    Syed, Izna Najam
    Tahir, Umair
    Noor, Tayyaba
    Choudhry, Muhammad Saad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (02)
  • [22] PEComa: what do we know so far?
    Hornick, JL
    Fletcher, CDM
    HISTOPATHOLOGY, 2006, 48 (01) : 75 - 82
  • [23] Autoimmune pancreatitis: What we know so far
    Masood, Muaaz
    JGH OPEN, 2022, 6 (01): : 3 - 10
  • [24] Mindful eating: what we know so far
    Tapper, Katy
    NUTRITION BULLETIN, 2022, 47 (02) : 168 - 185
  • [25] Covid-19: What do we know so far about a vaccine?
    Mahase, Elisabeth
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 369 : m1679
  • [26] What do We Know so Far about Ges Carbapenemases, and What Threat do They Pose?
    Rutkowski, Kamil
    Osnytskyy, Anton
    Slifierska, Magdalena
    Jarzabek, Paulina
    Bielec, Filip
    Pastuszak-Lewandoska, Dorota
    Brauncajs, Malgorzata
    ADVANCEMENTS OF MICROBIOLOGY, 2024, 63 (03) : 131 - 142
  • [27] What do we know about social media and firms' financial outcomes so far?
    Kizildag, Murat
    Altin, Mehmet
    Ozdemir, Ozgur
    Demirer, Ilhan
    JOURNAL OF HOSPITALITY AND TOURISM TECHNOLOGY, 2017, 8 (01) : 39 - 54
  • [28] What We Know So Far about Oil Theft in Mexico: Chiaroscuros of a Persistent Crime
    Peschard Mariscal, Jacqueline
    Salazar Rebolledo, Maria Grisel
    Olea Gomez, Octavio Augusto
    REVISTA MEXICANA DE CIENCIAS POLITICAS Y SOCIALES, 2021, 66 (241): : 245 - 280
  • [29] From Bench to Bedside: What Do We Know about Imidazothiazole Derivatives So Far?
    Guo, Mu
    Yu, Xiangbin
    Zhu, Yi Zhun
    Yu, Yue
    MOLECULES, 2023, 28 (13):
  • [30] Refractory hypertension: what do we know so far?
    Elizabeth Silaid Muxfeldt
    Bernardo Chedier
    Journal of Human Hypertension, 2021, 35 : 181 - 183